Affomix
Branford
About Affomix
Affomix has proprietary technology for rapid, automated, high-throughput selection of human monoclonal antibodies (mAbs). Their mission is to commercialize proprietary mAbs, mAb microarrays and mAb libraries for research, drug discovery, diagnostic and therapeutic applications, with a particular focus on the use of their mAbs for sensitive and accurate measurement of very large numbers of proteins in biological samples.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $7.0M
- Funding stage: M&A
- Last round: Series A (Feb 2008)
- Website: affomix.com
- Phone: +1 (203)481-6400
Industries & Categories
Biotechnology, Health Care
Canonical: https://fsome.com/organization/affomix-2667927 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.